| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM199610173351603 |
| P698 | PubMed publication ID | 8815940 |
| P50 | author | Renu Virmani | Q88208229 |
| Frank D Kolodgie | Q96240690 | ||
| P2093 | author name string | Semigran MJ | |
| Narula J | |||
| Hajjar RJ | |||
| Khaw BA | |||
| Schmidt U | |||
| Haider N | |||
| Dec GW | |||
| DiSalvo TG | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 1182-1189 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Apoptosis in myocytes in end-stage heart failure | |
| P478 | volume | 335 |
| Q50761995 | 30-year follow-up of a patient with classic citrullinemia. |
| Q34997938 | A mechanistic role for cardiac myocyte apoptosis in heart failure |
| Q39168641 | A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis |
| Q59793418 | A novel model of reno-cardiac syndrome in the C57BL/ 6 mouse strain |
| Q37961568 | A review of causes and systemic approach to cardiac troponin elevation |
| Q36015485 | A synopsis of research in cardiac apoptosis and its application to congestive heart failure |
| Q36380672 | Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity |
| Q35080715 | Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis |
| Q42357842 | Acute CD47 Blockade During Ischemic Myocardial Reperfusion Enhances Phagocytosis-Associated Cardiac Repair |
| Q33622671 | Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis |
| Q36326143 | Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis |
| Q74299670 | Adenosine decreases post-ischaemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation |
| Q40793049 | Adenosine protects against angiotensin II-induced apoptosis in rat cardiocyte cultures |
| Q33963576 | Adriamycin-induced heart failure: mechanism and modulation |
| Q27334044 | Adult cardiac progenitor cell aggregates exhibit survival benefit both in vitro and in vivo |
| Q64967935 | Advanced Evolution of Pathogenesis Concepts in Cardiomyopathies. |
| Q37640935 | AgNORs in the myocardium in ischaemic heart disease complicated by heart failure: a postmortem study |
| Q38596695 | Aging Effects on Cardiac Progenitor Cell Physiology |
| Q35916459 | Aging might increase myocardial ischemia / reperfusion-induced apoptosis in humans and rats |
| Q33525546 | Alcohol dehydrogenase accentuates ethanol-induced myocardial dysfunction and mitochondrial damage in mice: role of mitochondrial death pathway |
| Q33204659 | Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways. |
| Q55020147 | Allicin improves cardiac function by protecting against apoptosis in rat model of myocardial infarction. |
| Q81430605 | Alterations in both death and survival signals for apoptosis in heart failure due to volume overload |
| Q47236508 | Altered expression of high-molecular-weight calmodulin-binding protein in human ischaemic myocardium |
| Q90681544 | An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure |
| Q58715274 | Anastasis: recovery from the brink of cell death |
| Q33637455 | Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice |
| Q50508773 | Angiotensin II does not induce apoptosis but rather prevents apoptosis in cardiomyocytes. |
| Q33182432 | Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. |
| Q36294478 | Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis |
| Q37483527 | Annexin A5-functionalized nanoparticle for multimodal imaging of cell death |
| Q38542462 | Anthracycline-Induced Cardiomyopathy in Adults |
| Q55691637 | Anti-Apoptosis and Anti-Fibrosis Effects of Eriobotrya Japonica in Spontaneously Hypertensive Rat Hearts. |
| Q35196622 | Anti-apoptosis effect of polysaccharide isolated from the seeds of Cuscuta chinensis Lam on cardiomyocytes in aging rats |
| Q88601156 | Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death/degeneration |
| Q44932061 | Anti-apoptotic effect of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation |
| Q36261207 | Antibodies for molecular imaging in the cardiovascular system |
| Q52992219 | Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis--evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis. |
| Q44959302 | Antioxidant and oxidative stress changes in experimental cor pulmonale |
| Q42078470 | Apoptosis after reperfused myocardial infarction: Role of angiotensin II. |
| Q84967221 | Apoptosis and acute cellular rejection in human heart transplants |
| Q37828669 | Apoptosis and congestive heart failure |
| Q36080910 | Apoptosis and oncosis in acute coronary syndromes: assessment and implications |
| Q33181075 | Apoptosis and proliferation of cardiomyocytes in heart failure of different etiologies |
| Q34490923 | Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes |
| Q81576039 | Apoptosis at a distance: remote activation of caspase-3 occurs early after myocardial infarction |
| Q34490943 | Apoptosis in cardiac transplant rejection |
| Q73136840 | Apoptosis in congestive heart failure induced by viral myocarditis in mice |
| Q30846548 | Apoptosis in dilated cardiomyopathy |
| Q36895340 | Apoptosis in experimental myocardial infarction in situ and in the perfused heart in vitro |
| Q74732633 | Apoptosis in heart failure |
| Q73622523 | Apoptosis in heart failure: is there light at the end of the tunnel (TUNEL)? |
| Q36417773 | Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy |
| Q34491000 | Apoptosis in myocardial ischemia, infarction, and altered myocardial states |
| Q74842139 | Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis? An endomyocardial biopsy study |
| Q74635681 | Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance |
| Q34629107 | Apoptosis in the cardiovascular system |
| Q63915349 | Apoptosis in the cardiovascular system: incidence, regulation, and therapeutic options |
| Q77802842 | Apoptosis in the failing heart |
| Q34490952 | Apoptosis in the genesis of cardiac rhythm disorders |
| Q43084454 | Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. |
| Q73029234 | Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy |
| Q37298308 | Apoptosis predominates in nonmyocytes in heart failure |
| Q24314624 | Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation |
| Q73352327 | Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: observations made after implantation of left ventricular assist device |
| Q37063437 | Apoptosis: a potentially reversible, meta-stable state of the heart |
| Q77903369 | Apoptosis: the good and the bad--possible future therapeutic implications |
| Q37263689 | Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling |
| Q74257419 | Apoptotic versus autophagic cell death in heart failure |
| Q36422461 | Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise? |
| Q39578214 | Association between the severity of heart failure and the susceptibility of myocytes to apoptosis in patients with idiopathic dilated cardiomyopathy |
| Q38622547 | Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor |
| Q37148557 | BDNF-mediates Down-regulation of MicroRNA-195 Inhibits Ischemic Cardiac Apoptosis in Rats |
| Q36278847 | BNIP3 promotes calcium and calpain-dependent cell death |
| Q34078104 | BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions |
| Q51590993 | BRCA1 Reflects Myocardial Adverse Remodeling in Idiopathic Dilated Cardiomyopathy. |
| Q34180951 | Berberine inhibits norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via inhibiting ROS-TNF-α-caspase signaling pathway |
| Q33858191 | Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse |
| Q44392529 | Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes |
| Q37280784 | Beta3 integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy |
| Q57236046 | Burden of myocardial damage in cardiac allograft rejection: Scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis |
| Q92432561 | CARDIOVASCULAR COMPLICATIONS OF ACROMEGALY |
| Q48240860 | CRTH2 promotes endoplasmic reticulum stress-induced cardiomyocyte apoptosis through m-calpain. |
| Q37899670 | CaMKII in the cardiovascular system: sensing redox states. |
| Q33788492 | Calcium channel blockers, apoptosis and cancer: is there a biologic relationship? |
| Q36290081 | Canstatin inhibits hypoxia-induced apoptosis through activation of integrin/focal adhesion kinase/Akt signaling pathway in H9c2 cardiomyoblasts |
| Q42909200 | Cardiac Contractile Dysfunction and Apoptosis in Streptozotocin-Induced Diabetic Rats Are Ameliorated by Garlic Oil Supplementation |
| Q34687837 | Cardiac apoptosis: from organ failure to allograft rejection. |
| Q34402700 | Cardiac macrophages and their role in ischaemic heart disease |
| Q88039803 | Cardiac molecular imaging to track left ventricular remodeling in heart failure |
| Q37566215 | Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3L. |
| Q40831915 | Cardiac remodeling as a consequence and cause of progressive heart failure. |
| Q34043589 | Cardiac remodeling in obesity. |
| Q33852546 | Cardiac signal transduction |
| Q50617474 | Cardiac toxicity by sublethal 2,3,7,8-tetrachlorodibenzo-p-dioxin correlates with its anti-proliferation effect on cardiomyocytes in zebrafish embryos. |
| Q74128600 | Cardiac troponin I as diagnostic and prognostic marker in severe heart failure |
| Q33741038 | Cardiac troponins in congestive heart failure |
| Q42605252 | Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations |
| Q78181096 | Cardiomyocyte apoptosis with enhanced expression of P53 and Bax in right ventricle after pulmonary arterial banding |
| Q51828037 | Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators. |
| Q33626253 | Cardioprotection by CaMKII-deltaB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. |
| Q28534567 | Cardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of S-propargyl-cysteine on heart failure rats and molecular mechanisms |
| Q37641746 | Cardiovascular effects of leptin |
| Q36268105 | Cardiovascular effects of the thiazolidinediones. |
| Q36903477 | Caspases in myocardial infarction. |
| Q35612808 | Causes and characteristics of diabetic cardiomyopathy |
| Q77802850 | Cell cycle control in the terminally differentiated myocyte. A platform for myocardial repair? |
| Q40774230 | Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. |
| Q36425263 | Cell death in the cardiovascular system |
| Q35500618 | Cell death signalling mechanisms in heart failure. |
| Q36287930 | Cell death, tissue hypoxia and the progression of heart failure |
| Q28513099 | Cellular Disorganization and Extensive Apoptosis in the Developing Heart of Mice that Lack Cardiac Muscle α-Actin: Apparent Cause of Perinatal Death |
| Q38725113 | Cellular apoptosis in the cardiorenal axis |
| Q24647295 | Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives |
| Q33674213 | Cellular stress responses: cell survival and cell death |
| Q44857336 | Changes in cell cycling and apoptosis contribute to reduced effector cell generation among long-term heart transplant survivors |
| Q33338375 | Characterization of a novel cardiac isoform of the cell cycle-related kinase that is regulated during heart failure |
| Q37729162 | Chronic ethanol consumption up-regulates protein-tyrosine phosphatase-1B (PTP1B) expression in rat skeletal muscle |
| Q57298849 | Chronic right ventricular pressure overload results in a hyperplastic rather than a hypertrophic myocardial response |
| Q24804131 | Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure |
| Q84117985 | Circulating p53 and cytochrome c levels in acute myocardial infarction patients |
| Q44485638 | Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium |
| Q36332855 | Clinical modifiers for heart failure following myocardial infarction |
| Q78245306 | Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure |
| Q35075375 | Combination of epinephrine with esmolol attenuates post-resuscitation myocardial dysfunction in a porcine model of cardiac arrest |
| Q41194503 | Combination stem cell therapy for heart failure |
| Q93019313 | Common laboratory parameters as indicators of multi-organ dysfunction in acute heart failure |
| Q79365871 | Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure |
| Q74471688 | Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy |
| Q44526029 | Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts |
| Q53344976 | Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). |
| Q77298825 | Coronary artery constriction in rats: necrotic and apoptotic myocyte death |
| Q44048974 | Coxsackievirus B4-induced neuronal apoptosis in rat cortical cultures |
| Q34426884 | Critical role of insulin‑like growth factor binding protein‑5 in methamphetamine‑induced apoptosis in cardiomyocytes |
| Q33688965 | Current and novel pharmacologic approaches in advanced heart failure |
| Q74660339 | Current and novel pharmacologic approaches in advanced heart failure |
| Q36269884 | DNA Repair Gene Polymorphism and the Risk of Mitral Chordae Tendineae Rupture |
| Q73289068 | Death Hath a Thousand Doors To Let Out Life… |
| Q28591672 | Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice |
| Q47671926 | Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation |
| Q78298410 | Deoxyribonucleic acid damage/repair proteins are elevated in the failing human myocardium due to idiopathic dilated cardiomyopathy |
| Q50010483 | Detecting Anastasis In Vivo by CaspaseTracker Biosensor |
| Q73450651 | Detection of DNA fragmentation of myonuclei in myotonic dystrophy by double staining with anti-emerin antibody and by nick end-labeling |
| Q80611710 | Detection of TUNEL-positive cardiomyocytes and c-kit-positive progenitor cells in children with congenital heart disease |
| Q35546856 | Detection of apoptosis using in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon? |
| Q50422218 | Developmental and degenerative cardiac defects in the Taiwanese mouse model of severe spinal muscular atrophy. |
| Q30390478 | Dichotomous actions of NF-kappaB signaling pathways in heart |
| Q42389083 | Differential Regulation of Bcl-xL Gene Expression by Corticosterone, Progesterone, and Retinoic Acid |
| Q34344775 | Dilated cardiomyopathy caused by aberrant endoplasmic reticulum quality control in mutant KDEL receptor transgenic mice |
| Q37382594 | Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart |
| Q74495207 | Distinct initiator caspases are required for the induction of apoptosis in cardiac myocytes during ischaemia versus reperfusion injury |
| Q43823412 | Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats |
| Q37072564 | Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure? |
| Q36275682 | Don't lose heart--therapeutic value of apoptosis prevention in the treatment of cardiovascular disease. |
| Q34773776 | Doxorubicin-induced apoptosis: implications in cardiotoxicity |
| Q33927271 | Dual autonomous mitochondrial cell death pathways are activated by Nix/BNip3L and induce cardiomyopathy |
| Q33181618 | Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes |
| Q28580617 | Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis |
| Q33624348 | Dysregulated IER3 Expression is Associated with Enhanced Apoptosis in Titin-Based Dilated Cardiomyopathy |
| Q74210510 | Early and persistent activation of myocardial apoptosis, bax and caspases: insights into mechanisms of progression of heart failure |
| Q55292605 | Effect of Allicin against Ischemia/Hypoxia-Induced H9c2 Myoblast Apoptosis via eNOS/NO Pathway-Mediated Antioxidant Activity. |
| Q84551764 | Effect of polysaccharides extract of rhizoma atractylodis macrocephalae on thymus, spleen and cardiac indexes, caspase-3 activity ratio, Smac/DIABLO and HtrA2/Omi protein and mRNA expression levels in aged rats |
| Q41975237 | Effects of Astragaloside IV on heart failure in rats |
| Q33634702 | Effects of calcium channel blockers on cellular apoptosis: implications for carcinogenic potential |
| Q41584823 | Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats. |
| Q45341410 | Efferocytosis and Outside-In Signaling by Cardiac Phagocytes. Links to Repair, Cellular Programming, and Intercellular Crosstalk in Heart |
| Q48504109 | Efficacy of intramyocardial injection of Algisyl-LVR for the treatment of ischemic heart failure in swine. |
| Q47575675 | Electro-mechanical characteristics of myocardial infarction border zones and ventricular arrhythmic risk: novel insights from grid-tagged cardiac magnetic resonance imaging |
| Q43540799 | Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis |
| Q33855758 | EndoG links Bnip3-induced mitochondrial damage and caspase-independent DNA fragmentation in ischemic cardiomyocytes |
| Q36286936 | Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure |
| Q37379734 | Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes |
| Q85106793 | Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress |
| Q77802794 | Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity |
| Q92307638 | Epicardial prestrained confinement and residual stresses: a newly observed heart ventricle confinement interface |
| Q52562835 | Exercise induces new cardiomyocyte generation in the adult mammalian heart. |
| Q50461855 | Exogenous midkine administration prevents cardiac remodeling in pacing-induced congestive heart failure of rabbits. |
| Q44925667 | Experimental animal model for anthracycline-induced heart failure. |
| Q35543238 | Expression of a naturally occurring angiotensin AT(1) receptor cleavage fragment elicits caspase-activation and apoptosis |
| Q34488508 | Expression of a transgene encoding mutant p193/CUL7 preserves cardiac function and limits infarct expansion after myocardial infarction |
| Q35195197 | Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia |
| Q35376319 | Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community |
| Q39737479 | Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload |
| Q35557461 | Fascination with bacteria-triggered cell death: the significance of Fas-mediated apoptosis during bacterial infection in vivo |
| Q37228759 | Features of cardiomyocyte proliferation and its potential for cardiac regeneration. |
| Q28215640 | Functional consequences of caspase activation in cardiac myocytes |
| Q43225042 | G-protein inactivator RGS6 mediates myocardial cell apoptosis and cardiomyopathy caused by doxorubicin. |
| Q91606337 | Gene Therapy for Heart Failure: New Perspectives |
| Q34490969 | Gene therapy and pharmaceutical modulation of apoptosis |
| Q35724614 | Gene transfer in cardiac myocytes. |
| Q35106501 | Genetic editing of dysfunctional myocardium |
| Q37365912 | Ginsenoside rb1 reduces isoproterenol-induced cardiomyocytes apoptosis in vitro and in vivo |
| Q34438892 | Globular adiponectin protects H9c2 cells from palmitate-induced apoptosis via Akt and ERK1/2 signaling pathways |
| Q33738009 | Growth hormone therapy for heart failure: swimming against the stream |
| Q40670845 | H9c2 cardiac myoblasts undergo apoptosis in a model of ischemia consisting of serum deprivation and hypoxia: inhibition by PMA. |
| Q37600641 | Having a change of heart: reversing the suicidal proclivities of cardiac myocytes. |
| Q73356859 | Heart failure in arrhythmogenic right ventricular dysplasia-cardiomyopathy |
| Q34739129 | Heart failure in the young |
| Q33934894 | Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. |
| Q44654247 | Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro |
| Q28480869 | High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation |
| Q46309853 | Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model |
| Q73853044 | Histological remodeling in an ovine heart failure model resembles human ischemic cardiomyopathy |
| Q58492256 | Histopathologic changes in asymptomatic relatives of patients with idiopathic dilated cardiomyopathy. |
| Q35753015 | Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis |
| Q38312321 | Human serum induces apoptosis of xenogenic cardiomyocytes in vivo and in vitro |
| Q28577311 | Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. |
| Q34184425 | Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1. |
| Q33853515 | Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. |
| Q34114841 | IFATS collection: Human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function |
| Q37222188 | Imaging left ventricular remodeling: targeting the neurohumoral axis |
| Q37377105 | Immunological mechanisms of pentoxifylline in chronic heart failure |
| Q92803859 | Immunometabolic cross-talk in the inflamed heart |
| Q47313325 | Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy. |
| Q34401857 | Implications of recent heart failure trials for patients with hypertension |
| Q33766517 | In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure |
| Q90391076 | In vivo detection of programmed cell death during mouse heart development |
| Q35763784 | In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy |
| Q34491965 | In vivo fluorometric assessment of cyclosporine on mitochondrial function during myocardial ischemia and reperfusion |
| Q43196441 | Increased B-type-natriuretic peptide promotes myocardial cell apoptosis via the B-type-natriuretic peptide/long non-coding RNA LSINCT5/caspase-1/interleukin 1β signaling pathway |
| Q77535879 | Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure |
| Q35376458 | Increased formation of F(2)-isoprostanes in patients with severe heart failure |
| Q73061824 | Increased p53 protein expression in human failing myocardium |
| Q44164912 | Indium 111 antimyosin and Tc-99m glucaric acid for noninvasive identification of oncotic and apoptotic myocardial necrosis |
| Q37280058 | Infarction induced myocardial apoptosis and ARC activation |
| Q37147171 | Inflammatory Markers-Serum Level of C-Reactive Protein, Tumor Necrotic Factor-α, and Interleukin-6 as Predictors of Outcome for Peripartum Cardiomyopathy |
| Q33655472 | Influence of glucosamine on glomerular mesangial cell turnover: implications for hyperglycemia and hexosamine pathway flux |
| Q35100887 | Inhibition of Na+/H+-exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial beta-adrenoceptor system in failing rabbit hearts. |
| Q34047552 | Inhibition of apoptosis by progesterone in cardiomyocytes |
| Q43818884 | Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects |
| Q35753293 | Inhibition of microRNA-497 ameliorates anoxia/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagy |
| Q37772818 | Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices |
| Q50062606 | Inotropes and vasopressors in acute heart failure, when the devil dresses as an angel |
| Q35626056 | Ins and outs of apoptosis in cardiovascular diseases |
| Q49300240 | Insights from Second-Line Treatments for Idiopathic Dilated Cardiomyopathy |
| Q35745296 | Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis |
| Q37031992 | Intervention for apoptosis in cardiomyopathy |
| Q35763693 | Intracellular signaling pathways for norepinephrine- and endothelin-1-mediated regulation of myocardial cell apoptosis |
| Q35844633 | Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy |
| Q64060313 | Intracoronary Gene Delivery of the Cytoprotective Factor Vascular Endothelial Growth Factor-B in Canine Patients with Dilated Cardiomyopathy: A Short-Term Feasibility Study |
| Q36934608 | Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy |
| Q80538036 | Introduction-cell death in heart failure |
| Q35414513 | Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade |
| Q58842444 | Is apoptosis a mechanism of cell death of cardiomyocytes in chronic chagasic myocarditis? |
| Q73622517 | Is apoptosis present in progression to chronic hypertensive heart failure? |
| Q52536744 | Ischemia-reperfusion in the adult mouse heart influence of age. |
| Q28566993 | Janus kinase-2 signaling mediates apoptosis in rat cardiomyocytes |
| Q38712625 | Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l-mediated mitochondrial fission |
| Q44559477 | Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytes |
| Q74337599 | Left ventricular function and endomyocardial biopsy in early and advanced dilated cardiomyopathy |
| Q47335718 | Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy. |
| Q47790482 | Levels of soluble Fas ligand in myocarditis |
| Q34833218 | Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. |
| Q35763055 | Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation. |
| Q83816869 | Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure |
| Q34357873 | Low-intensity aerobic interval training attenuates pathological left ventricular remodeling and mitochondrial dysfunction in aortic-banded miniature swine |
| Q34995311 | Mechanical stress-induced apoptosis in the cardiovascular system |
| Q41669348 | Mechanism of action of beta-blocking agents in heart failure |
| Q35697472 | Mechanisms of apoptosis in the heart |
| Q42332637 | Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment |
| Q36661551 | Mechanisms of disease: apoptosis in heart failure--seeing hope in death |
| Q36699897 | Mechanisms of disease: detrimental adrenergic signaling in acute decompensated heart failure |
| Q46359834 | Mechanistic Role of Thioredoxin 2 in Heart Failure |
| Q77802846 | Medical therapy of chronic heart failure. Role of ACE inhibitors and beta-blockers |
| Q64095068 | Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction |
| Q40036237 | MicroRNA-20a inhibits stress-induced cardiomyocyte apoptosis involving its novel target Egln3/PHD3. |
| Q37036751 | Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study |
| Q51772665 | Minor troponin T elevation in patients 6 months after acute myocardial infarction: an observational study. |
| Q37206330 | Mitochondria and heart failure: new insights into an energetic problem |
| Q38019459 | Mitochondria in heart failure: the emerging role of mitochondrial dynamics |
| Q35006528 | Mitochondria, nitric oxide, and cardiovascular dysfunction. |
| Q37054218 | Mitochondrial centrality in heart failure |
| Q44020107 | Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy |
| Q33572241 | Mitochondrial function as a determinant of life span |
| Q38737214 | Mitochondrial involvement in myocyte death and heart failure |
| Q58738081 | Modulation of apoptosis-related microRNAs following myocardial infarction in fat-1 transgenic mice vs wild-type mice |
| Q64380266 | Molecular Aspects of Myocarditis |
| Q37785825 | Molecular Changes Occurring During Reverse Remodelling Following Left Ventricular Assist Device Support |
| Q37435637 | Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure. |
| Q24814079 | Molecular and cellular mechanisms of cardiotoxicity |
| Q41669341 | Molecular and cellular mechanisms of myocardial failure |
| Q34658321 | Molecular and cellular mechanisms of myocardial remodeling |
| Q35724669 | Molecular biology of myocardial recovery |
| Q36497703 | Molecular control of bacterial death and lysis |
| Q37441796 | Molecular imaging of cell death |
| Q38597820 | Molecular switches under TGFβ signalling during progression from cardiac hypertrophy to heart failure |
| Q36430856 | Morphological aspects of apoptosis in heart diseases |
| Q32872245 | Multifaceted roles of miR-1s in repressing the fetal gene program in the heart |
| Q36080491 | Mutation of the calmodulin binding motif IQ of the L-type Ca(v)1.2 Ca2+ channel to EQ induces dilated cardiomyopathy and death |
| Q77083012 | Myocardial DNA strand breaks are detected in biopsy tissues from patients with dilated cardiomyopathy |
| Q37700358 | Myocardial Fas and cytokine expression in end-stage heart failure: impact of LVAD support |
| Q82917837 | Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction |
| Q57236023 | Myocardial cell damage in human hypertension |
| Q73832161 | Myocardial cell death and apoptosis in hibernating myocardium |
| Q52536924 | Myocardial cell death in fibrillating and dilated human right atria. |
| Q44008848 | Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol. |
| Q33853869 | Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure |
| Q37338684 | Myocardial scaffold-based cardiac tissue engineering: application of coordinated mechanical and electrical stimulations |
| Q39790463 | Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53 |
| Q42194690 | Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium |
| Q77976715 | Myocyte loss in chronic heart failure |
| Q36221185 | Myocyte proliferation in end-stage cardiac failure in humans |
| Q38205363 | Myocyte renewal and therapeutic myocardial regeneration using various progenitor cells |
| Q36593277 | Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies |
| Q35949674 | Neovascularization derived from cell transplantation in ischemic myocardium. |
| Q33941111 | Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function |
| Q73450838 | Nifedipine does not induce but rather prevents apoptosis in cardiomyocytes |
| Q33610146 | Nitric oxide and apoptosis |
| Q37556067 | Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart |
| Q34963276 | Nitric oxide, cell death, and heart failure |
| Q38349356 | Noncoding RNAs as regulators of cardiomyocyte proliferation and death |
| Q73226897 | Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy |
| Q35260701 | Noninvasive molecular imaging of apoptosis in a mouse model of anthracycline-induced cardiotoxicity |
| Q36666482 | Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review |
| Q42540132 | Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol |
| Q90077681 | Novel myocardial markers GADD45G and NDUFS5 identified by RNA-sequencing predicts left ventricular reverse remodeling in advanced non-ischemic heart failure: a retrospective cohort study |
| Q37766810 | Origin of cardiac progenitor cells in the developing and postnatal heart |
| Q36689735 | Overexpression of Tbx20 in Adult Cardiomyocytes Promotes Proliferation and Improves Cardiac Function After Myocardial Infarction. |
| Q37373506 | Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy |
| Q35708066 | Oxidant-induced iron signaling in Doxorubicin-mediated apoptosis |
| Q58915024 | Oxidative stress and heart failure in altered thyroid States |
| Q34027493 | Oxidative stress in congestive heart failure |
| Q39761047 | PET imaging of in vivo caspase-3/7 activity following myocardial ischemia-reperfusion injury with the radiolabeled isatin sulfonamide analogue [(18)F]WC-4-116 |
| Q46390109 | Pandora's Box: mitochondrial defects in ischaemic heart disease and stroke. |
| Q78319496 | Paradoxical effects of metalloporphyrins on doxorubicin-induced apoptosis: scavenging of reactive oxygen species versus induction of heme oxygenase-1 |
| Q36762401 | Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo |
| Q73808573 | Partial reversion of left ventricle remodeling in cardiomyopathy patients by means of transthoracic microelectrostimulation |
| Q35146909 | Pathogenetic basis of myocardial dysfunction and amenability to reversal |
| Q34239875 | Pathophysiology of chronic heart failure |
| Q36342542 | Pathways of myocyte death: implications for development of clinical laboratory biomarkers |
| Q84906681 | Peri-infarct dysfunction in post-myocardial infarction: assessment of 3-T tagged and late enhancement MRI |
| Q34357219 | Pericytes at the intersection between tissue regeneration and pathology |
| Q33893265 | Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. |
| Q50917391 | Persistence of apoptosis and inflammatory responses in the heart and bone marrow of mice following whole-body exposure to ²⁸Silicon (²⁸Si) ions. |
| Q33828487 | Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. |
| Q50957589 | Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. |
| Q33679417 | Postmitochondrial regulation of apoptosis during heart failure |
| Q92881879 | Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection |
| Q38648931 | Predictors and clinical implication of high-sensitivity cardiac troponin-I elevation following diagnostic cardiac catheterisations. |
| Q43418638 | Premature death and age-related cardiac dysfunction in male eNOS-knockout mice |
| Q33152812 | Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy |
| Q41715319 | Prevention of ventricular remodeling |
| Q37051197 | Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. |
| Q73564989 | Programmed cell death in the myocardium of arrhythmogenic right ventricular cardiomyopathy in children and adults |
| Q24300092 | Prolyl hydroxylase 3 interacts with Bcl-2 to regulate doxorubicin-induced apoptosis in H9c2 cells |
| Q46256707 | Propofol limits rat myocardial ischemia and reperfusion injury with an associated reduction in apoptotic cell death in vivo |
| Q85183493 | Protective effects of novel single compound, Hirsutine on hypoxic neonatal rat cardiomyocytes |
| Q34482464 | Quantifying acute myocardial injury using ratiometric fluorometry |
| Q64123698 | Quantitative temporal analysis of protein dynamics in cardiac remodeling |
| Q28078529 | Rat Heterotopic Heart Transplantation Model to Investigate Unloading-Induced Myocardial Remodeling |
| Q35724728 | Reading tarot cards |
| Q35376406 | Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline |
| Q37121628 | Regulation of cell survival by Na+/H+ exchanger-1. |
| Q36816705 | Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; The role of NADPH oxidase 4 |
| Q28576035 | Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy |
| Q36827885 | Return to the fetal gene program protects the stressed heart: a strong hypothesis |
| Q36179543 | Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure |
| Q46251652 | Role of (pro)rennin receptor in cardiomyocytes of heart failure rat model |
| Q88711590 | Role of Cardiac Troponin Levels in Acute Heart Failure |
| Q36203123 | Role of apoptosis in ventricular remodeling |
| Q26858965 | Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology |
| Q36557850 | Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance |
| Q38793550 | Safflower extract inhibiting apoptosis by inducing autophagy in myocardium derived H9C2 cell |
| Q24816032 | Second-hand smoke-induced cardiac fibrosis is related to the Fas death receptor apoptotic pathway without mitochondria-dependent pathway involvement in rats |
| Q36792634 | Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases |
| Q36766849 | Sequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathy |
| Q36837596 | Serial High-Sensitivity Troponin T in Post-Primary Angioplasty Exercise Test |
| Q92241300 | Serum apoptotic marker M30 is positively correlated with early diastolic dysfunction in adolescent obesity |
| Q73457007 | Serum levels of soluble form of Fas molecule in patients with congestive heart failure |
| Q51767161 | Short telomeres - A hallmark of heritable cardiomyopathies. |
| Q38768739 | Signaling Pathways in Cardiac Myocyte Apoptosis. |
| Q33720346 | Simultaneous loss of phospholipase Cδ1 and phospholipase Cδ3 causes cardiomyocyte apoptosis and cardiomyopathy |
| Q37673022 | Small-animal SPECT and SPECT/CT: application in cardiovascular research. |
| Q78025780 | Soluble tumor necrosis factor receptor levels identify a subgroup of heart failure patients with increased cardiomyocyte apoptosis |
| Q38997197 | Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy |
| Q35517542 | Stem and progenitor cell therapy for pulmonary arterial hypertension: effects on the right ventricle (2013 Grover Conference Series). |
| Q37708148 | Stem cells for heart failure in the aging heart |
| Q40006145 | Stem cells from in- or outside of the heart: isolation, characterization, and potential for myocardial tissue regeneration |
| Q37380055 | Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell |
| Q41999813 | Structural remodelling in heart failure. |
| Q78828688 | Study on apoptosis and expression of P53, bcl-2, Bax in cardiac myocytys of congestive heart failure induced by ventricular pacing |
| Q60492166 | Subacute Inflammatory Activation in Subjects with Acute Coronary Syndrome and Left Ventricular Dysfunction |
| Q74319220 | Sudden cardiac death in patients with congestive heart failure: toward a unified rational treatment approach |
| Q41840270 | T cell apoptosis in human heart allografts: association with lack of co-stimulation? |
| Q41779490 | TNF-alpha-mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy |
| Q41847856 | Tanshinone IIA inhibits apoptosis in the myocardium by inducing microRNA-152-3p expression and thereby downregulating PTEN. |
| Q39823505 | Targeting BNIP3 in inflammation-mediated heart failure: a novel concept in heart failure therapy |
| Q35095412 | Targeting ischemic cardiac dysfunction through gene transfer |
| Q33186831 | Taurine Renders the Cell Resistant to Ischemia-induced Injury in Cultured Neonatal Rat Cardiomyocytes |
| Q42937750 | Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion |
| Q33916607 | The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs |
| Q40245145 | The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy |
| Q55004256 | The Chinese Herb Yi-Qi-Huo-Xue Protects Cardiomyocyte Function in Diabetic Cardiomyopathy. |
| Q92923287 | The Role of Bone Morphogenetic Protein 7 (BMP-7) in Inflammation in Heart Diseases |
| Q27686758 | The cell biology of disease: cellular mechanisms of cardiomyopathy. |
| Q44557796 | The correlation between expression of apoptosis-related proteins and myocardial functional reserve evaluated by dobutamine stress echocardiography in patients with dilated cardiomyopathy. |
| Q77682180 | The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure |
| Q36567862 | The emerging role for type 5 phosphodiesterase inhibition in heart failure |
| Q37625460 | The existence of myocardial repair: mechanistic insights and enhancements |
| Q36761301 | The influence of diabetes on cardiac beta-adrenoceptor subtypes |
| Q37139791 | The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion |
| Q37466802 | The mitochondrial ubiquitin ligase plays an anti-apoptotic role in cardiomyocytes by regulating mitochondrial fission |
| Q77726717 | The necessary role of the autopsy in cardiovascular epidemiology |
| Q74660329 | The pathophysiology of advanced heart failure |
| Q35724546 | The potential role of ventricular compressive therapy |
| Q40964541 | The role of TNF-α, Fas/Fas ligand system and NT-proBNP in the early detection of asymptomatic left ventricular dysfunction in cancer patients treated with anthracyclines |
| Q33178678 | The role of apoptosis in dilated cardiomyopathy |
| Q34329506 | The role of apoptotic cell death in cardiovascular disease |
| Q33701510 | The role of growth hormone and insulin-like growth factor I in the regulation of apoptosis |
| Q34222988 | The role of nitric oxide in the failing heart |
| Q43018678 | The role of the neurohormonal system in heart failure. |
| Q34427722 | Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis. |
| Q37420907 | Thyroid hormones and antioxidant systems: focus on oxidative stress in cardiovascular and pulmonary diseases |
| Q36719726 | Tomato lycopene attenuates myocardial infarction induced by isoproterenol: electrocardiographic, biochemical and anti-apoptotic study. |
| Q28580391 | Transgenic overexpression of the adenine nucleotide translocase 1 protects cardiomyocytes against TGFβ1-induced apoptosis by stabilization of the mitochondrial permeability transition pore |
| Q40489196 | Treating relentlessly progressive congestive heart failure: what next? |
| Q80000799 | Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis |
| Q48173387 | Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. |
| Q57312532 | Tumor necrosis factor in congestive heart failure: A mechanism of disease for the new millennium? |
| Q34127393 | Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications |
| Q92253324 | Unsupervised classification of multi-omics data during cardiac remodeling using deep learning |
| Q35810247 | Up-regulation of AT(1) and AT(2) receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death |
| Q73858799 | Upregulation of the Bcl-2 family of proteins in end stage heart failure |
| Q44271819 | Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure |
| Q36239617 | Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart |
| Q77802811 | Ventricular remodeling. Mechanisms and prevention |
| Q34014180 | Wearable multi-channel microelectrode membranes for elucidating electrophysiological phenotypes of injured myocardium. |
| Q47104776 | When signalling goes wrong: pathogenic variants in structural and signalling proteins causing cardiomyopathies |
| Q77296406 | Why does the myocardium fail? Insights from basic science |
| Q36596197 | Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury |
| Q79449729 | [Advances in cardiovascular medicine through molecular imaging] |
| Q73587540 | [Apoptosis in cardiovascular diseases] |
| Q52535812 | [Cell death in inflammatory heart muscle diseases--apoptosis or necrosis?]. |
| Q74043498 | [New pharmacological agents in heart failure] |
| Q83105952 | [Pathophysiology of chronic heart failure] |
| Q58845962 | [Serum troponin T in patients with chronic Chagas disease] |
| Q73538106 | [The clinical practice guidelines of the Sociedad Española de Cardiología on cardiomyopathies and myocarditis] |
| Q28593416 | bcl-2 overexpression promotes myocyte proliferation |
| Q36265845 | miR-23a binds to p53 and enhances its association with miR-128 promoter |
| Q34634348 | β₂ AR agonists in treatment of chronic heart failure: long path to translation |
Search more.